GeneDxWGS
那斯達克 · USD
87.80
+1.93
(+2.25%)
盤中 09/10 12:48 (UTC+8)
09/10 12:48 (UTC+8)
GeneDxWGS
87.80
+1.93
(+2.25%)
財務數據
損益表
- 0.62
- 0.71
- 0.77
- 0.96
- 0.87
- 1.03
- 1.17
- 1.21
- 1.02
- 1.14
- 8.72
- 12.96
- 9.02
- 24.41
- -8.91
- 17.88
- 13.68
- 3.64
- -15.48
- 11.92
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 114,440 | 102,254 | 120,989 | 116,743 | 102,692 | 87,115 | 95,640 | 76,874 | 70,514 | 62,422 |
營業成本 | 36,202 | 34,043 | 36,721 | 32,216 | 31,790 | 28,639 | 29,435 | 29,045 | 27,562 | 25,011 |
營業毛利 | 78,238 | 68,211 | 84,268 | 84,527 | 70,902 | 58,476 | 66,205 | 47,829 | 42,952 | 37,411 |
營業費用 | 95,693 | 125,682 | 98,503 | 87,778 | 61,942 | 63,027 | 57,399 | 55,609 | 53,320 | - |
研發費用 | 19,656 | 19,804 | 24,541 | 19,829 | 15,079 | 12,577 | 11,588 | 11,665 | 10,691 | 11,567 |
推銷及管理費用 | 76,037 | 74,591 | 73,962 | 67,949 | 46,863 | 50,450 | 45,811 | 43,944 | 42,629 | 39,504 |
非經常性項目費用 | - | 31,287 | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -15,243 | -57,471 | -14,235 | -3,251 | 9,033 | -4,551 | 8,806 | -7,780 | -10,579 | -13,660 |
其他收入及費用 | 382 | -4,231 | -3,475 | -3,575 | 2,420 | -891 | -2,694 | 264 | -17,890 | -6,064 |
利息費用 | 1,185 | 717 | -2,019 | 562 | 817 | 640 | -2,334 | -1,491 | 894 | 597 |
稅前純益 | -18,258 | -62,419 | -18,230 | -7,388 | 10,563 | -6,082 | 5,414 | -8,359 | -29,363 | -20,321 |
所得稅 | -518 | 897 | -564 | 247 | -246 | 447 | -24 | -47 | -190 | -82 |
稅後純益 | -17,740 | -63,316 | -17,666 | -7,635 | 10,809 | -6,529 | 5,438 | -8,312 | -29,173 | -20,239 |
基本每股稅後盈餘(元) | -0.60 | -2.16 | -0.61 | -0.27 | 0.38 | -0.23 | 0.25 | -0.31 | -1.10 | -0.78 |
稀釋每股稅後盈餘(元) | -0.59 | -2.16 | -0.61 | -0.26 | 0.37 | -0.23 | 0.23 | -0.29 | -1.10 | -0.78 |
基本平均股數(千股) | 29710.00 | 29335.00 | 29043.00 | 28797.00 | 28579.00 | 28147.00 | 27790.00 | 27095.00 | 26617.00 | 26062.00 |
稀釋平均股數(千股) | 29710.00 | 29335.00 | 27869.00 | 28797.00 | 29753.00 | 28147.00 | 27790.00 | 27095.00 | 26617.00 | 26062.00 |
還原基本每股稅後盈餘(元) | -0.60 | -2.16 | -0.61 | -0.27 | 0.38 | -0.23 | 0.25 | -0.31 | -1.10 | -0.78 |
還原稀釋每股稅後盈餘(元) | -0.59 | -2.16 | -0.61 | -0.26 | 0.37 | -0.23 | 0.23 | -0.29 | -1.10 | -0.78 |
還原基本平均股數(千股) | 29,710 | 29,335 | 29,043 | 28,797 | 28,579 | 28,147 | 27,790 | 27,095 | 26,617 | 26,062 |
還原稀釋平均股數(千股) | 29,710 | 29,335 | 27,869 | 28,797 | 29,753 | 28,147 | 27,790 | 27,095 | 26,617 | 26,062 |
EBITDA(千元) | -10,359 | -54,893 | -13,368 | -352 | 17,571 | 236 | 8,638 | -3,921 | -23,251 | -14,476 |